Psoriasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18-65 years ; 2. Diagnosed with psoriasis according to the clinical diagnostic criteria of the 'Chinese Guidelines for Diagnosis and Treatment of Psoriasis' with disease duration =6 months; 3. Baseline PASI score of 3-10; 4. Baseline BSA of 3-10% 5. Signed informed consent form; 6. Meeting at least one of the following conditions: i. Previous attempts to discontinue corticosteroids resulted in PASI rebound >=50% within 2 weeks ii. Requires topical corticosteroid application >=3 times per week to maintain disease stability Patients must meet all 6 criteria above to be included in the study.
Exclusion criteria
Exclusion criteria: 1.Generalized pustular psoriasis or erythrodermic psoriasis; 2.Concurrent severe gastrointestinal diseases hepatic or renal dysfunction immunodeficiency disorders or severe psychiatric conditions; 3.Pregnant or breastfeeding women; 4.History of allergy to calcipotriol or corticosteroids; 5.Participation in other clinical trials within the past month; 6.Systemic use of immunosuppressants or biologics within the past 4 weeks Subjects meeting any of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PASI 50 response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Relapse Rate;Duration of Medication Effectiveness;PASI 75 Response Rate;Physician/Patient Global Assessment;Change in Dermatology Life Quality Index;Days to PASI =2;Pittsburgh Sleep Quality Index Score;Depression (PHQ-9) Scale Scores;Anxiety;Cumulative Dosage of Topical Medications;Percentage change in BSA; | — |
Countries
China
Contacts
Chengdu Pidu District Hospital of Traditional Chinese Medicine